SCHRODINGER INC

Inside Schrodinger’s latest insider trades, executives lock in gains while still holding long‑term positions – what this means for investors and the company’s future.

Schrödinger Inc.’s CFO sells 875 shares to cover RSU taxes – a routine move amid a 7% weekly decline, highlighting insiders’ long‑term stake and caution for investors.

Insider grants at Schrodinger signal strong confidence in future drug‑discovery gains, aligning executives with shareholders while market remains undervalued.

Insider buys at Schrodinger signal confidence amid volatility—executive purchases and a drug‑discovery pipeline boost investor sentiment and may hint at future upside.